Related content

Citrulline and anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis

By Yamada Ryo   Suzuki Akari   Yamamoto Kazuhiko  

Future Rheumatology, Vol. 1, Iss. 2, 2006-04 ,pp. : 249-258

Future Medicine

Access to resources Recommend Favorite

Contribution of HLA-DRB1*04 alleles and anti-cyclic citrullinated antibodies to development of resistance to disease-modifying antirheumatic drugs in early rheumatoid arthritis

By Mori Shunsuke   Hirose Jun   Yonemura Kensuke  

Clinical Rheumatology, Vol. 29, Iss. 12, 2010-12 ,pp. : 1357-1366

Springer Publishing Company

Access to resources Recommend Favorite

Predictive value of antibodies to cyclic citrullinated peptide in patients with early arthritis

By Ateş Aşkın   Karaaslan Yaşar   Aksaray Sebahat  

Clinical Rheumatology, Vol. 26, Iss. 4, 2007-04 ,pp. : 499-504

Springer Publishing Company

Access to resources Recommend Favorite

Association of Anti-cyclic Citrullinated Peptide Antibodies with Clinical and Radiological Disease Severity in Rheumatoid Arthritis

By  

Current Rheumatology Reviews, Vol. 10, Iss. 2, 2014-09 ,pp. : 136-143

Bentham Science Publishers

Access to resources Recommend Favorite

Second generation anti-cyclic citrullinated peptide (anti-CCP2) antibodies can replace other anti-filaggrin antibodies and improve rheumatoid arthritis diagnosis

By Grootenboer-Mignot S   Nicaise-Roland P   Delaunay C   Meyer O   Chollet-Martin S   Labarre C  

Scandinavian Journal of Rheumatology, Vol. 33, Iss. 4, 2004-07 ,pp. : 218-220

Informa Healthcare

Access to resources Recommend Favorite